Onvatilimab (JNJ-61610588) is a human IgG1?? monoclonal antibody that targets VISTA (V-domain Ig Suppressor of T-cell Activation), a protein involved in the negative regulation of T-cell responses. This antibody exhibits potent anti-tumor activity by modulating the immune system's ability to recognize and destroy cancer cells. Onvatilimab is primarily researched for its therapeutic potential in oncology, particularly in enhancing immune-mediated tumor suppression.
Onvatilimab (JNJ-61610588) is a human IgG1?? monoclonal antibody that targets VISTA (V-domain Ig Suppressor of T-cell Activation), a protein involved in the negative regulation of T-cell responses. This antibody exhibits potent anti-tumor activity by modulating the immune system's ability to recognize and destroy cancer cells. Onvatilimab is primarily researched for its therapeutic potential in oncology, particularly in enhancing immune-mediated tumor suppression.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
